In a pivotal trial of Science’s Prima BCI, 84% of patients impacted by dry AMD were able to read again once fitted with the technology.

Science Corp., a biotech startup focused on brain-computer interface technologies, announced Thursday that it has closed on a ...

Science has added a whole lot more cash to the bank, bringing in an impressive $230 million in its latest raise. | Science has added a whole lot more cash to the bank, bringing in an impressive $230 ...

Science Corporation, a competitor of Elon Musk's Neuralink, offers a brain-computer interface retinal implant designed to ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

Image courtesy of Science Corp.] Science Corporation announced today that it closed an oversubscribed $230 million Series C financing round. Lightspeed Venture Partners, Khosla Ventures, Y Combinator, ...

DelveInsight's Implanted Brain-Computer Interface Devices Market Insights report provides the current and forecast market ...

The MarketWatch News Department was not involved in the creation of this content. Verified Market Research(R) a leading provider of business intelligence and market analysis is thrilled to announce ...

China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.

NEW YORK--(BUSINESS WIRE)--Synchron, a category-defining brain-computer interface (BCI) company, announced today a step forward in implantable BCI technology to drive the future of neurotechnology.

Brain-computer interface experiments began more than 20 years ago Technology decodes brain signals that control speech and movement Elon Musk's Neuralink is a major player in field, along with ...